Evidence map›Paper›PMID 37147423›Full record

ArticleLeukemia2023

Relationship among three common hematological premalignant conditions.

Nicholas J Boddicker, Sameer A Parikh, Aaron D Norman, Kari G Rabe, Rosalie Griffin, Timothy G Call, Dennis P Robinson, Janet E Olson, Angela Dispenzieri, Vincent Rajkumar and 9 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Nicholas J BoddickerDivision of Computational Biology, Mayo Clinic, Rochester, MN, USA.
Sameer A ParikhDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-3221-7314
Aaron D NormanDivision of Epidemiology, Mayo Clinic, Rochester, MN, USA.
Kari G RabeDivision of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-7313-1875
Rosalie GriffinDivision of Computational Biology, Mayo Clinic, Rochester, MN, USA.
Timothy G CallDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
Dennis P RobinsonDivision of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.
Janet E OlsonDivision of Epidemiology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-4944-7789
Angela DispenzieriDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-8780-9512
Vincent RajkumarDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
Shaji KumarDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-5392-9284
Neil E KayDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-5951-5055
Curtis A HansonDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
James R CerhanDivision of Epidemiology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-7482-178X
David MurrayDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-1720-335X
Esteban BraggioDepartment of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USA.ORCID 0000-0003-3860-4830
Tait D ShanafeltDepartment of Medicine, Division of Hematology, Stanford University, Stanford, CA, USA.
Celine M Vachon *Division of Epidemiology, Mayo Clinic, Rochester, MN, USA. Vachon.Celine@mayo.edu.ORCID 0000-0002-1962-9322
Susan L Slager *Division of Computational Biology, Mayo Clinic, Rochester, MN, USA. Slager.Susan@mayo.edu.ORCID 0000-0002-5173-4712

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Project 4: Targeting Resistance to T-Cell Directed Therapy in Multiple MyelomaP50CA186781 · NCI · MAYO CLINIC ARIZONA · PI Rafael Fonseca · 2015 to 2026
$25.5M
Impact of Genetic susceptibility along the continuum from MGUS to MM (Supplement)U01CA271014 · NCI · MAYO CLINIC ROCHESTER · PI Elizabeth E Brown, SHAJI Kunnathu KUMAR · 2022 to 2026
$3.4M
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)R01AG058266 · NIA · MAYO CLINIC ROCHESTER · PI SHANAFELT, TAIT D, SLAGER, SUSAN L · 2018 to 2022
$3.2M
Integration of germline and tumor genomes in CLLR01CA235026 · NCI · MAYO CLINIC ROCHESTER · PI BRAGGIO, ESTEBAN, SLAGER, SUSAN L · 2019 to 2023
$3.2M
NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA186781NCI NIH HHS R01 CA235026NCI NIH HHS U01 CA271014NIA NIH HHS R01 AG058266
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematologic DiseasesPrecancerous ConditionsHumans

Identifiers

PMID37147423
PMCPMC10400408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.